Navigation Links
Blood Cancer Patients May Benefit From New Transplant Technique
Date:12/13/2012

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, Dec. 12 (HealthDay News) -- Researchers who have multiplied umbilical cord-blood cells in the laboratory say their technique might improve recovery for patients needing blood stem cell transplants to treat a blood cancer.

Their approach, still in the experimental stage, involves expanding normal blood cells from donated cord blood in conditions similar to those in bone marrow. This greatly enlarges the supply needed for transplant. And because umbilical cord blood is more easily matched in patients than donor bone marrow, the recovery period is safer and shorter, the researchers said.

"Since our very first patients, we had a very strong signal [of success]," said Dr. Marcos de Lima, who led the study while at the University of Texas M.D. Anderson Cancer Center in Houston.

"Recipients of cord-blood transplants are less likely to have some of the complications with the same degree of matching with bone marrow transplants. So if we can be less picky with the matching, immediately our inventory is bigger," said de Lima, now a professor of medicine at Case Western Reserve University School of Medicine in Cleveland.

For the study, scientists at M.D. Anderson multiplied blood cells from one of two cords transplanted into 31 patients suffering from blood-borne cancers such as leukemia, lymphoma and myeloma. Compared to 80 patients receiving a standard double-cord blood transplant, these patients established a normal blood supply faster and were more likely to survive 100 days post-transplant.

The study is published Dec. 13 in the New England Journal of Medicine.

Each year more than 100,000 cases of blood, bone marrow and lymph node cancers are diagnosed in the United States, and more than 50,000 people die from these cancers, according to the U.S. Centers for Disease Control and Prevention. For many of these patients, the only chance of a cure lies in stem cells retrieved from bone marrow, peripheral blood or umbilical cord transplants, which can re-establish a normal blood supply after diseased cells are destroyed by chemotherapy and/or radiation.

The blood stem cells can develop into any type of blood cell -- white, red or platelets.

But only about 25 percent of those needing a blood stem cell transplant have a matching donor, which can complicate or sabotage the patient's recovery. While cord blood is more easily matched genetically, de Lima said, even two cords provide far fewer cells needed by adult recipients than bone marrow or peripheral blood donations.

In the lab, de Lima and his colleagues took blood from one of the two donated umbilical cords and expanded it on a bed of so-called mesenchymal precursor cells, which in the bone marrow serve to grow a healthy blood supply.

The amount of time it took for the expanded cord blood cells to "engraft" -- or firmly establish -- in patients was significantly quicker than in the comparison group, leading to less risk of complications from low numbers of white blood cells and platelets, which fight infection and control bleeding, respectively.

One expert welcomed the findings.

"Cord blood and transplant doctors have been trying over the years to increase the number of stem cells in test tubes, and those methods have slowly been developing. This report is the first important study where this is not only feasible but practical," said Dr. Kanti Rai, a hematologist/oncologist with the North Shore-LIJ Health System in New Hyde Park, N.Y. "If this methodology can become reproducible in other people's hands ... then it opens a whole new opportunity for cancer patients."

Stressing that the results need to be duplicated in late-stage trials, de Lima refused to speculate how the new cord blood expansion method might affect cure rates.

"What we're offering folks is a less toxic [treatment] and hopefully a transplant that would be safer, with a shorter stay in the hospital," he said. "I hope it may one day improve the so-called cure rates simply because more people will survive this initial [period]."

More information

The U.S. Centers for Disease Control and Prevention has more information on blood cancers.

SOURCES: Marcos de Lima, M.D., professor, medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, formerly M.D. Anderson Cancer Center, Houston; Kanti Rai, M.D., hematologist/oncologist, North Shore-LIJ Health System, New Hyde Park, N.Y.; Dec. 13, 2012, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Cancer Patients May Benefit From New Transplant Technique
(Date:4/28/2017)... ... 2017 , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit ... at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical ... to donate. , “Women’s Hospital at Renaissance has been a collection partner for ...
(Date:4/28/2017)... Boston, MA (PRWEB) , ... April 28, 2017 , ... ... just for older people. “Wearing a hearing aid doesn’t have the stigma it had ... Speech-Language & Hearing Associates of Greater Boston, in a NALA North American Speaker ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... celebrating its 5th anniversary. SearchLight is the premier online modeling resource for fluorescence ... more than 30,000 active users during last 5 years spanning the globe, SearchLight ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: